Impact of Resistance Training Intensity on Blood Pressure
Recruiting now NCT06845514
Run by Université de Sherbrooke · for 50 to 70 · Women · accepts healthy volunteers
What this study is about
The goal of the clinical trial is to understand the effect of two resistance training protocols employing different loading intensities (% of 1 repetition maximum; 1-RM), but with standardized effort intensity (2 repetitions in reserve; RIR) on post-exercise and ambulatory blood pressure in aging females. The main questions it aims to answer are: * to examine the acute effects of low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise with a standardized high effort intensity on post-exercise hypotension and ambulatory blood pressure responses in aging females; * deepen the understanding of the mechanisms underlying acute reductions in blood pressure in response to resistance exercise performed at different load intensities. To this end, autonomic activity will be estimated alongside the measurement of central arterial compliance (i.e., carotid artery), and serum biomarkers of endothelial function; * document the affective valence and enjoyment associated with low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise when performed at a high perceived effort. Researchers will compare the effect of: 1) a low load (LL-RE) intensity protocol consisting of 3 sets of each exercise at 50% 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 2) high load (HL-RE) intensity protocol consisting of 3 sets of each exercise at 80% of 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 3) and a control condition (CON) consisting of a standardized non-fatiguing cognitive task. Participants will participate in: * A preliminary assessment visit; * Two familiarization visits to validate the exercise prescriptions; * Three experimental visits (CON, LL-RE, HL-RE).
Who can join (things the study team will check)
✅ You may be able to join if…
- aged 50 to 70 years;
- absence of menstruation for 12 consecutive months;
- normal-high resting blood pressure (120 ≤ Systolic ≤ 139 mmHg and 80 ≤ Diastolic ≤ 89 mmHg) or stage 1 hypertension (140 ≤ Systolic ≤ 159 mmHg or 90 < Diastolic ≤ 99 mmHg);
- physically inactive (< 150 minutes of structured aerobic physical activity per week);
- and not engaging in regular resistance exercise (≥ 2 sessions per week) for more than 3 months during the year.
🚫 You may not be able to join if…
- orthopedic limitations or other contraindications to resistance exercise;
- scheduled surgery during the study;
- unstable hypertension (≥ 160/100 mmHg);
- diagnosis of type 2 diabetes;
- cardiovascular event in the past 6 months or sequelae preventing exercise;
- and initiation of hormonal replacement therapy (< 4 months) known to affect blood pressure.
Where this trial is running
- Research Center on Aging, Sherbrooke, Quebec, Canada
Who to contact
Eléonor Riesco, Ph.D. · 819-821-8000 · e.riesco@usherbrooke.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06845514.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.